Recently, we have shown that dexamethasone treatment of rabbits specifically reduces vascular smooth muscle responsiveness to agonists that interact with the vascular thromboxane A2 / prostaglandin H2 (TXA2 / PGH2) receptor. One potential site at which dexamethasone can influence prostanoid-mediated vasoconstriction may be at the level of the vascular TXA2 IPGH2 receptor. Therefore, we characterized the vascular TXA2/PGH2 receptor in rabbit aortic membranes and examined the influence of dexamethasone treatment on vascular TXA2 IPGH2 receptor affinity and number. The binding of [1251] were obtained with the stereoisomers L657925(-) and L657926(+). Collectively, these data suggest that this binding site represents the functionally relevant vascular TXA2 IPGH2 receptor.
One potential site at which dexamethasone can interfere with prostanoid-induced vasoconstriction may be at the level of the vascular TXA2/PGH2 receptor(s). Therefore, the purpose of the present study is to characterize the vascular TXA2/PGH2 receptor in rabbit aortic membranes by using the newly synthesized ligand [1S-(lc,2,83(5Z),3a(1E,3R),4a]-7-[3-(3-hydroxy-4-(p-iodophenoxy)-1-butenyl)-7-oxabicyclo [ L657 ,926(+)13 were gifts from Dr. John Gillard of Merck-Frost Canada Inc., Point Claire-Dorval, Quebec, Canada. CGS 13080 was provided by CIBA-GEIGY Corp., Summit, N.J.
Animals
Male New Zealand White rabbits (2.0-2.5 kg) were treated for 6 consecutive days with daily subcutaneous injections of dexamethasone 21-acetate (2.5 mg/kg) suspended in sesame oil. Control rabbits received sesame oil only (0.5 ml) during the treatment period. On day 6, control and dexamethasone-treated rabbits were anesthetized by an intramuscular injection of ketamine HCI (Ketaset, 50 mg/kg, Aveco Co., Fort Dodge, Iowa) and xylazine (Rompun, 8 mg/kg, Mobay Co., Shawnee, Kan.), and the thoracic aortas were excised. For characterization of the vascular TXA2/PGH2 receptor, only aortas from control rabbits were used.
Preparation of Vascular Membranes
After excision, thoracic aortas were rapidly placed into ice-cold phosphate-buffered saline (10 mM phosphate buffer with 140 mM NaCl, pH 7.4) containing indomethacin (10 .tM) to inhibit endogenous prostaglandin synthesis, and the periadventitial fat was removed. In some experiments, the vascular endothelium was disrupted by rubbing the intimal surface of the vessel with a cotton-tipped swab. Aortas were blotted dry, immediately frozen in liquid nitrogen, and stored at -70°C until use. Routinely, 10-20 aortas were pooled for each membrane preparation. For preparation of aortic membranes, frozen tissues were pulverized and placed into 25 mM Tris buffer (1 g/10 ml, pH 7.4) containing sucrose (0.25 M), indomethacin (10 KM), EDTA (1 mM), phenylmethylsulfonylfluoride (1 mM), soybean trypsin inhibitor (10 ,g/ml), leupeptin (1 j,g/ml), and pepstatin (1 ,g/ml). After homogenization with a Polytron homogenizer (Brinkmann Instruments, Inc., Westbury, N.Y.) (three bursts at setting 5, each burst for 20 seconds), the aortic homogenate was centrifuged at 1,000g for 15 minutes, and the resulting supernatant was subsequently centrifuged at 10,000g for 15 minutes. Vascular membranes were obtained by centrifugation of the 10,000g supernatant at 100,000g for 90 minutes. The membrane pellet was resuspended in 25 mM HEPES buffer (pH 7.4) containing indomethacin (10 lM) and was frozen in liquid nitrogen and stored at -70°C until use. The specific activity of the plasma membrane marker enzyme, 5-nucleotidase, measured in the 100,000g pellet was similarly increased in aortic preparations from vehicle-treated (27.7-fold) and dexamethasone-treated (23.9-fold) rabbits.
Protein concentrations were determined by the method of Bradford,14 using bovine serum albumin as a protein standard. Rabbit thoracic aortas were excised and placed into cold Krebs' bicarbonate buffer (pH 7.4), the periadventitial fat was removed, and the vessels were cut into 2-3-mm-wide rings. A maximum of four aortic rings from each control and dexamethasonetreated rabbit was studied. The composition of the Krebs' bicarbonate solution was (mM) NaCl 118.5, KCl 4.7, CaCl2 2.5, KH2P04 1.2, MgSO4. 7H20 1.1, NaHCO3 25.0, and dextrose 5.6. Arterial rings were mounted in 5 -ml water-jacketed organ baths containing Krebs' bicarbonate buffer maintained at 370 C and continuously gassed with 95% 02-5% CO2. The vascular rings were equilibrated under 2 g of resting tension for 1.5-2.0 hours. The buffer was changed at 15-minute intervals, and basal tension was adjusted as required during the equilibration period. Two grams of basal tone were optimal for concentrationresponse curves to agonists in aortic rings. Changes in tension were measured using force transducers (model FTO3c, Grass Instruments, Quincy, Mass.) coupled to a Grass polygraph (model RPS 7C8A).
In experiments using aortic rings from control rabbits to examine the contractile responses to [ [1271]BOP (500 nM) initiated the rapid dissociation of specifically bound [1251]BOP from its membrane binding site, with a half-time of dissociation of 6.5 minutes (Figure 3) . After linear transformation of the data, the first-order rate constant for dissociation, k-1, was 0.248 min-l. By using the kobs and k-1 values, the true first-order association constant, kl, was calculated (see "Materials and Methods") to be 0.154 min-1, and the kinetically determined Kd was 0.620 nM.
To ascertain the specificity of [ branes from control and dexamethasone-treated rabbits (data not shown). Scatchard analysis of equilibrium binding studies (Figure 7 ) in membranes from control and dexamethasone-treated rabbits revealed no significant change in the affinity of the receptor for the ligand (Kd=0.43±0.11 and 0.28+0.03 for control and dexamethasone-treated rabbits, respectively, n=5 different membrane preparations) with a significant reduction in Bmax from 114.0+7.1 fmol/mg protein in membranes from vehicle-treated rabbits to 84.8±6.7 fmol/mg protein in membranes from dexamethasone-treated rabbits (p<0.05, Figure 8 
